|
All Business Categories
|
MedImmune , Inc.
Maryland, USA MedImmune, Inc., is a leading biotechnology company focused on researching, developing, and commercializing products to prevent or treat infectious disease, autoimmune disease, and... Anadys Pharmaceuticals , Inc. California, USA Anadys Pharmaceuticals, Inc., www.anadyspharma.com, is a biopharmaceutical company committed to advancing patient care by discovering, developing and commercializing novel small mo... Genzyme Corporation Massachusetts, USA One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. This year marks the 25th an... Elan Corporation , plc New York, USA Elan Corporation, plc (NYSE: ELN) is focused on the discovery, development, manufacturing, selling and marketing of novel therapeutic products in neurology, severe pain and autoimm... Biogen Idec Inc. California, USA Biogen Idec creates new standards of care in oncology, neurology and immunology. As a global leader in the development, manufacturing, and commercialization of novel therapies, Bio... British Columbia, Canada Currently enrolling clinical trial to study an experimental treatment using verteporfin and red light (photodynamic therapy) for the treatment of multiple basal cell carcinoma. Exonhit Therapeutics SA Maryland, USA ExonHit Therapeutics is the world's leader in the analysis of alternative RNA splicing, a process which when deregulated plays a key role in the onset of various diseases. ExonHit ... OXiGENE , Inc. Massachusetts, USA OXiGENE is an international biopharmaceutical company developing a portfolio of products that focus primarily on combating cancer. The Company´s initial product development is base... Cell New York, USA For over 25 years, Cell has remained at the forefront of exciting scientific developments, continually redefining the important areas of science with cutting-edge papers. Many of t... Curis , Inc. Massachusetts, USA Curis will be positioned to identify and successfully commercialize therapeutic opportunities derived from the human genome program , said Doros Platika , MD , president and chief ...
First
Prev
[1]
2
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[736]
[1453]
[2170]
Next
Last
|
